This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

Medline Inc.
11/4/2026
Good day and thank you for standing by. Welcome to MEDLINE's third quarter 2026 results conference call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question and answer session. To ask a question during the session, you'll need to press star 11 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, Please press star 11 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Karen King, Global Head of Investors.
Welcome to Medline's third quarter 2026 earnings conference call. This morning, we issued our earnings release and shared supplemental materials. Joining me on today's call are Jim Boyle, our Chief Executive Officer, and Mike Drazin, our Chief Financial Officer. During today's call, we may make forward-looking statements regarding our expectations for the future, including our business plans, strategy, and investments, and expected timing and impact. These statements are based on how we see things today, and actual results may differ materially due to risks and uncertainties. Please see the cautionary statements and risk factors contained in our earnings release which accompanies these remarks as well as our most recent 10-K and other SEC filings for more information regarding these risks and uncertainties. We will also reference non-GAAP financial measures which exclude certain items from our financial results calculated in accordance with GAAP. You can find a discussion of our non-GAAP financial measures and reconciliations to the comparable GAAP measures in the earnings release and the disclosures and non-GAAP reconciliations that accompany these remarks, which are available at our website at ir.medline.com under quarterly results. With that, I will now turn the call over to our CEO, Jim Boyle.
Thank you, Karen, and good morning, everyone. We executed well during the quarter, delivering strong broad-based growth. Third quarter net sales increased 10% as compared to the third quarter of 2025. Net sales for Medline Brand grew 7% with growth across all product categories, and supply chain solutions grew 14%, driven by new customer implementations and growth within existing customers. Adjusted EBITDA rose 12% to $1 billion. Strong sales growth and tariff refunds drove the increase, partially offset First, customer signings. We had another strong quarter of total new customer signs across multiple channels, including an agreement to supply physician offices for one of the largest health systems in the United States and a contract to serve the hospital labs of a large Midwest nonprofit integrated delivery network. Based on our results so far this year and the strength of our pipeline, we're confident in reaching our full year goal of $1 billion. Second, Canada. We're very encouraged by the progress we're making in Canada with our first Prime Vendor partnership with Mohawk Medvi. We're now live at five hospitals delivering strong service levels and receiving positive customer feedback. We expect to finish the rollout by the end of the first quarter of 2027, marking an important step in bringing our Prime Vendor model to Canada. Third, Tracy. We're nearing an important milestone in Northern California following the Our new distribution center in Tracy is on track to open by year end, adding capacity to serve customers across the region. The facility will include our largest single auto store installation to date, automating the picking of less-than-case items, which we expect to improve throughput and efficiency in mid-2027. Fourth, network capacity. Beyond Tracy, we're making significant investments across our distribution network. We're adding millions of square feet of distribution space at three new facilities with auto store automation, increasing capacity and operational flexibility across our distribution network. In March, we announced plans to construct a 1.2 million square foot distribution center in Dallas, Fort Worth. In July, we announced plans to open a new distribution center in Southern California, adding another 1 million square feet to support healthcare providers across the state. And recently, we announced that we are building an 800,000 square foot facility in Michigan to support customer demand in that region. that will help make our supply chain more resilient and responsive. Fifth, quality. I want to provide an update on the progress we're making under our global quality action plan. Patient safety and product quality remain paramount. As part of the plan, we have engaged independent third parties to conduct assessments across our more than 30 manufacturing sites worldwide. Given the breadth of our global network, we expect these assessments to be a multi-year effort. We're also investing in people, processes, and many more. These investments, based on what we know today, are reflected in our 2026 guidance and our 2027 framework, which Mike will discuss here in a moment. Overall, we're pleased by the momentum we're seeing and the progress we're making against our priorities. We're on track to achieve our total new customer signings goal, expand our distribution capacity and advance our global quality action plan. At the same time, we remain focused on navigating near-term margin pressure, as Mike will discuss shortly, while continuing to invest in the capabilities to support our customers and drive long-term growth. With that, I'll turn the call over to Mike to walk through our financial performance and outlook.
You're reading a preview of the MDLN Q3 2026 earnings call.
Free account.
Want transcripts like this in your own app? Try the Earnings call API, or read the transcript API docs.
Use this data in your own app
Pull this call's transcript, audio and slides with the Earnings call transcripts API.
See pricing